NotableSocialBloombergΒ·Bloomberg
Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use
Merck & Co.'s Ervebo vaccine and Gilead Sciences' Remdesivir antiviral drug will be deployed for wider use in eastern Democratic Republic of Congo. This deployment aims to control the fastest-growing Ebola outbreak recorded to date.
Impact Score
4/10
Thursday, August 6, 2026 at 11:07 PM EDT
Read original source β